Latest News | Dr Reddy's Launches Generic Product of BioMarin's Kuvan in US Market
Get latest articles and stories on Latest News at LatestLY. Dr Reddy's Laboratories on Wednesday said it has launched Sapropterin Dihydrochloride Powder for Oral Solution, which is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA), in the US market.
New Delhi, Apr 7 (PTI) Dr Reddy's Laboratories on Wednesday said it has launched Sapropterin Dihydrochloride Powder for Oral Solution, which is indicated to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA), in the US market.
The company's product is the generic version of BioMarin's Kuvan which has been approved by the US Food and Drug Administration (USFDA), Dr Reddy's Laboratories said in a statement.
The product demonstrates that the company is actively expanding the breadth of its portfolio with a treatment for a rare disease, it said.
The Hyderabad-based firm said its product is available in 100 mg unit dose packets in a 30 count carton.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)